Full-Time

Validation Engineer

Updated on 12/20/2024

ProKidney

ProKidney

51-200 employees

Develops cell therapy for chronic kidney disease

Biotechnology
Healthcare

Junior, Mid

Winston-Salem, NC, USA

Category
QA & Testing
Quality Assurance
Requirements
  • Associate degree in Science/Engineering or related field with 0-3 years of work experience.
  • 1-3 years of related validation experience in a cGMP environment.
  • Basic knowledge of root cause analysis, risk assessment, and investigation tools/techniques in cGMP.
  • Minimum of 3 years of prior experience developing, authoring, and executing validation protocols in a manufacturing environment.
  • Knowledge and understanding of the validation lifecycle.
  • Strong Mechanical aptitude
  • Strong technical writing skills.
  • Experience with equipment qualification methodologies.
  • Ability to read/interpret P&ID drawings.
Responsibilities
  • Lead validation projects to include planning, scheduling execution and reports.
  • Develop and Author Validation/Qualification protocols at the manufacturing facility for cleaning processes, equipment, utility, and facilities.
  • Execute validation/qualification protocols for cleaning processes, equipment, utility, and facilities.
  • Prepare validation/qualification summary reports for the executed protocols with support and guidance from senior level staff.
  • Contribute to the generation and review of required documentation (Standard Operating Procedures, protocols, change controls and change requests) to support validation activities and program.
  • Applies standard techniques and procedures to carry out a series of scientific and/or engineering tasks.
  • Provide adequate reporting and communication of projects to project manager, stakeholders and department manager.
  • Experience interacting with various groups at facility to develop plan/validation strategy for projects.
  • Experience interacting with project engineers to obtain the necessary information to fulfill validation documents.

ProKidney focuses on treating Chronic Kidney Disease (CKD) through a novel cell therapy called rilparencel. This therapy aims to preserve kidney function in patients with advanced CKD, potentially delaying or eliminating the need for dialysis, which many patients currently rely on. ProKidney is in the late stages of clinical trials for rilparencel, and early results indicate it may effectively maintain kidney function. Unlike other treatments, ProKidney specifically targets CKD, a condition affecting over 35 million adults in the U.S., filling a significant gap in available therapies. The company's goal is to provide a new treatment option that improves the quality of life for CKD patients and reduces their reliance on dialysis.

Company Stage

IPO

Total Funding

$559.3M

Headquarters

Winston-Salem, North Carolina

Founded

2015

Growth & Insights
Headcount

6 month growth

24%

1 year growth

40%

2 year growth

112%
Simplify Jobs

Simplify's Take

What believers are saying

  • ProKidney raised $140 million to fuel CKD therapeutic breakthroughs.
  • Increased interest in cell therapy enhances ProKidney's market position.
  • Growing biotech-insurance partnerships could improve rilparencel's patient access.

What critics are saying

  • Cancelled Greensboro expansion may harm ProKidney's local reputation.
  • Increased manufacturing expenses could strain ProKidney's financial resources.
  • Volatile stock price may impact investor confidence and future funding.

What makes ProKidney unique

  • ProKidney is pioneering rilparencel, a novel cell therapy for CKD.
  • Rilparencel aims to delay or eliminate the need for dialysis in CKD patients.
  • ProKidney targets an underserved CKD market, offering a groundbreaking treatment option.

Help us improve and share your feedback! Did you find this helpful?